| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |